Contact
Please use this form to send email to PR contact of this press release:
Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea
TO:
Please use this form to send email to PR contact of this press release:
Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea
TO: